Acer Therapeutics Inc. Gains 109.84%
Thu, Aug 31, 2023 at 07:07 PM
Acer Therapeutics Inc. (ACER:NASDAQ) soared at $1.28, representing a gain of 109.8%. On Thu, Aug 31, 2023, ACER:NASDAQ touched a New 2-Week High of $1.28. The stock appeared on our News Catalysts scanner on Thu, Aug 31, 2023 at 12:50 PM in the 'BIOTECH' category. From Thu, Aug 17, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Aug 31, 2023 at $1.76 with a volume of 131M+.
About Acer Therapeutics Inc. (ACER:NASDAQ)
Acer Therapeutics Inc is a pharmaceutical company that acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 713.95%
- Aditxt Inc. (ADTX:NASDAQ), 461.22%
- Acer Therapeutics Inc. (ACER:NASDAQ), 109.84%
- Flora Growth Corp. (FLGC:NASDAQ), 77.31%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 60.76%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 43.08%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 36.19%
- Vinco Ventures Inc. (BBIG:NASDAQ), 33.33%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 33.11%
- Leafly Holdings Inc. (LFLY:NASDAQ), 32.81%